OncoMed and Celgene to jointly develop six cancer drugs

(Reuters) - OncoMed Pharmaceuticals Inc said Celgene Corp would develop and market six of its anti-cancer stem cell experimental drugs for an upfront payment of $155 million.

via Reuters: Health News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/12/oncomed-and-celgene-to-jointly-develop_3.html